X
Xenon Pharmaceuticals D
D
XENE
29.740
USD
-0.78
(-2.56%)
مغلق
حجم التداول
37,314
الربح لكل سهم
-4
العائد الربحي
-
P/E
-9
حجم السوق
2,282,057,234
الأخبار المقالات
العنوان: Xenon Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.